National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Limonene, (+)-

Synonyms

Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (4R)-

(4R)-1-methyl-4-prop-1-en-2-yl-cyclohexene

(R)-(+)-limonene

LIMONENE, (+)-

(4R)-1-methyl-4-(1-methylethenyl)cyclohexene

(+)-alpha-Limonene

Limonene, (+)-

(+)-limonene

(R)-4-isopropenyl-1-methylcyclohexene

1-methyl-4-isopropenyl-1-cyclohexene

Limonene, D-

(+)-(R)-4-isopropenyl-1-methylcyclohexene

(R)-1-Methyl-4-(1-methylethenyl)cyclohexene

Alda 341

Alda-341

Alda341

D-Limonene

Limonene

Definitions

An oral dietary supplement containing a natural cyclic monoterpene, and a major component of the oil extracted from citrus peels, with potential chemopreventive and antineoplastic activities. Upon oral administration, D-limonene activates aldehyde dehydrogenase 3A1 (ALDH3A1), thereby decreasing aldehyde level. This may protect salivary stem/progenitor cells (SSPCs) from toxic aldehydes and prevent or improve radiation-induced xerostomia. Limonene and its metabolites perillic acid, dihydroperillic acid, uroterpenol and limonene 1,2-diol may also inhibit tumor growth through inhibition of p21-dependent signaling and may induce apoptosis via the induction of the transforming growth factor beta-signaling pathway. In addition, they inhibit post-translational modification of signal transduction proteins, resulting in G1 cell cycle arrest as well as differential expression of cell cycle- and apoptosis-related genes.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61714

ALT_DEFINITION

A terpene with two isoprene units forming a ring. The chemical structure is CC1=CCC(CC1)C(=C)C.

CAS_Registry

5989-27-5

7705-13-7

CHEBI_ID

CHEBI:15382

Chemical_Formula

C10H16

code

C61714

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

Contributing_Source

CRCH

CTRP

FDA

GDC

DEFINITION

An oral dietary supplement containing a natural cyclic monoterpene, and a major component of the oil extracted from citrus peels, with potential chemopreventive and antineoplastic activities. Upon oral administration, D-limonene activates aldehyde dehydrogenase 3A1 (ALDH3A1), thereby decreasing aldehyde level. This may protect salivary stem/progenitor cells (SSPCs) from toxic aldehydes and prevent or improve radiation-induced xerostomia. Limonene and its metabolites perillic acid, dihydroperillic acid, uroterpenol and limonene 1,2-diol may also inhibit tumor growth through inhibition of p21-dependent signaling and may induce apoptosis via the induction of the transforming growth factor beta-signaling pathway. In addition, they inhibit post-translational modification of signal transduction proteins, resulting in G1 cell cycle arrest as well as differential expression of cell cycle- and apoptosis-related genes.

Display_Name

Limonene, (+)-

FDA_UNII_Code

GFD7C86Q1W

FULL_SYN

Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (4R)-

(4R)-1-methyl-4-prop-1-en-2-yl-cyclohexene

(R)-(+)-limonene

LIMONENE, (+)-

(4R)-1-methyl-4-(1-methylethenyl)cyclohexene

(+)-alpha-Limonene

Limonene, (+)-

(+)-limonene

(R)-4-isopropenyl-1-methylcyclohexene

1-methyl-4-isopropenyl-1-cyclohexene

Limonene, D-

(+)-(R)-4-isopropenyl-1-methylcyclohexene

(R)-1-Methyl-4-(1-methylethenyl)cyclohexene

Alda 341

Alda-341

Alda341

D-Limonene

Limonene

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Limonene, (+)-

Legacy Concept Name

D-Limonene

Maps_To

Limonene, (+)-

NCI_Drug_Dictionary_ID

664042

PDQ_Closed_Trial_Search_ID

664042

PDQ_Open_Trial_Search_ID

664042

Preferred_Name

Limonene, (+)-

prefixIRI

Thesaurus:C61714

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0950252

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C68542

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_15384 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_15384 OCMR LOOM
http://purl.obolibrary.org/obo/CHEBI_15384 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_15384 GO-PLUS LOOM
http://purl.obolibrary.org/obo/CHEBI_15384 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_15384 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_15384 DRON LOOM
http://purl.bioontology.org/ontology/RXNORM/1426477 RXNORM LOOM
http://purl.bioontology.org/ontology/RXNORM/1426476 RXNORM LOOM
http://stirdf.jst.go.jp/id/200907010163633715 IOBC LOOM
http://purl.bioontology.org/ontology/SNMI/C-31149 SNMI LOOM
http://purl.bioontology.org/ontology/MESH/D000077222 MESH LOOM
http://purl.bioontology.org/ontology/RXNORM/1426777 RXNORM LOOM
http://purl.obolibrary.org/obo/NCIT_C61714 BERO LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/11038000 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/RCD/X79EZ RCD LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C008281 RH-MESH LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#14289 OCHV LOOM
http://purl.bioontology.org/ontology/RXNORM/28730 RXNORM LOOM
http://purl.jp/bio/4/id/200906023325459561 IOBC LOOM
http://purl.obolibrary.org/obo/NCIT_C61709 BERO LOOM
http://purl.obolibrary.org/obo/UPa_UPC06078 UPA LOOM
http://purl.bioontology.org/ontology/RXNORM/1363991 RXNORM LOOM
http://purl.jp/bio/4/id/200906090981614033 IOBC LOOM
http://purl.bioontology.org/ontology/NDDF/007167 NDDF LOOM
http://purl.obolibrary.org/obo/SIBO_0000359 SIBO LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000664042 PDQ LOOM
http://stirdf.jst.go.jp/id/200907004949773006 IOBC LOOM
http://purl.obolibrary.org/obo/SIBO_0000223 SIBO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0064992 OCHV LOOM